Contraceptive Drugs Market Size Growing at 6.9% CAGR, Set to Reach USD 24.42 Billion By 2027, Exclusive Report

How big is the contraceptive drugs market?

According to the report published by Allied Market Research, the global Contraceptive Drugs Market was pegged at $14.32 billion in 2019, and is anticipated to garner $24.42 billion by 2027, manifesting a CAGR of 6.9% from 2020 to 2027. The study analyzes the important strategies, drivers, competition, market dynamics, size, and important investment regions.

Key Takeaways:

Oral Contraceptive Drugs segment would continue to maintain the lead over the forecast period.

15-24 years segment is projected as one of the most lucrative segment.

Household segment would continue to maintain the lead over the forecast period.

North America would continue to maintain the lead over the analysis period.

Request Sample Copy of the Report:

https://www.alliedmarketresearch.com/request-sample/9850

Major Factors Driving the Growth of Contraceptive Drugs Market:

• Rising Global Population: The world’s population continues to grow, leading to increased demand for effective family planning and contraceptive methods.
• Women’s Empowerment: Greater awareness of women’s rights and empowerment has led to increased demand for contraception to enable women to make informed choices about family planning and reproductive health.
• Advancements in Contraceptive Drug Development: Ongoing research and development efforts have led to the introduction of new and more effective contraceptive drugs, including long-acting reversible contraceptives (LARCs) like hormonal IUDs and implants.
• Expanding Access to Healthcare: Improving access to healthcare services and contraception in both developed and developing countries has enabled more people to seek and use contraceptive drugs.
• Educational Campaigns: Public health campaigns and educational initiatives aimed at raising awareness about family planning and contraception have led to increased usage of contraceptive drugs.
• Cultural and Societal Changes: Evolving societal norms and cultural changes have reduced the stigma associated with contraception, making it more widely accepted.
• Family Planning Programs: Government initiatives and healthcare organizations often promote family planning and contraception, making contraceptive drugs more accessible and affordable.

Market Segmentation:

Type of Contraceptive Drug:

• • Oral Contraceptives: These are taken orally (as pills) and are typically divided into combined oral contraceptives (COCs) containing estrogen and progestin, and progestin-only pills (POP) or mini-pills.
  • Injectable Contraceptives: Contraceptive drugs administered via injection, such as Depo-Provera (medroxyprogesterone acetate).
  • Implants: Contraceptive implants are subdermal devices that release hormones (e.g., Nexplanon).
  • Intrauterine Devices (IUDs): Devices inserted into the uterus, including hormonal IUDs (e.g., Mirena) and non-hormonal IUDs (e.g., ParaGard).
  • Vaginal Rings: Hormonal contraceptive rings, like the NuvaRing, are inserted into the vagina.

Hormonal vs. Non-Hormonal:

• • Separating contraceptive drugs based on whether they contain hormones (e.g., estrogen, progestin) or are hormone-free (e.g., copper IUDs).

Prescription vs. Over-the-Counter (OTC):

• • Distinguishing between contraceptive drugs that require a prescription from a healthcare provider and those available over-the-counter.

End User:

• • Women: Contraceptive drugs primarily used by women for birth control.
  • Men: Emerging contraceptive options for men, including male hormonal contraceptives.

By Region:

• North America  (U.S., Canada, Mexico)
• Europe  (Germany, France, UK, Rest of Europe)
• Asia-Pacific  (Japan, China, Australia, India, Rest of Asia-Pacific)
• LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Request for Customization – 

https://www.alliedmarketresearch.com/request-for-customization/9850

Regional Growth Dynamics:

The market is studied across various regions including Asia-Pacific, Europe, LAMEA, and North America. The market across North America held the major share in 2019, with around one-third of the global contraceptive drugs market. Moreover, the market across Asia-Pacific is expected to showcase the fastest CAGR of 8.4% from 2020 to 2027.

Competitive Landscape:

Novartis AG, Teva Pharmaceutical Industries Ltd., Piramal Healthcare, Bayer AG, Agile Therapeutics, Mylan N.V., Johnson & Johnson, Pfizer Inc., Allergan Plc., GlaxoSmithKline Plc.

Buy this Premium Research Report: 

https://www.alliedmarketresearch.com/purchase-enquiry/9850

Key Questions Answered in the Intelligent Study

What is the market size and growth rate of the global and regional market by various segments?
What is the market size and growth rate of the market for selective countries?
Which region or sub-segment is expected to drive the market in the forecast period?
What Factors are estimated to drive and restrain the market growth?
What are the key technological and market trends shaping the market?
What are the key opportunities in the market?
What are the key companies operating in the market?
Which company accounted for the highest market share?

Why Choose Allied Market Research?

Industries’ Best Analysts
Exclusive Product Offerings
Customer Research Services
Dynamics Research Methodology
Comprehensive Reports
Latest Technological Advancements
Value Chain Analysis
Future Market Opportunities
Market Growth Dynamics
Quality Assurance
Post-sales Support
Continuous Report Update

Market Dynamics and Transformations

Economic Downturn Analysis: Impact of Recession in 2023
Pandemic’s Influence: Impact of Covid-19 Pandemic
Market Evolution: Recent Developments in the Market with Key Players Announcements.

Similar Reports:

Oxygen Concentrators Market –  https://www.alliedmarketresearch.com/medical-oxygen-concentrators-market-A10874

Mobile Imaging Market – https://www.alliedmarketresearch.com/mobile-imaging-services-market-A10893

Rapid Acting Insulin Market – https://www.alliedmarketresearch.com/rapid-acting-insulin-market-A10599

South Korea Cell Culture Market- https://www.alliedmarketresearch.com/south-korea-cell-culture-market-A10562

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com